Digital Counting of Individual Molecules by Stochastic Attachment of Diverse Labels
US-2015005185-A1 · Jan 1, 2015 · US
US9290809B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9290809-B2 |
| Application number | US-201414540018-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 12, 2014 |
| Priority date | Dec 15, 2009 |
| Publication date | Mar 22, 2016 |
| Grant date | Mar 22, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compositions, methods and kits are disclosed for high-sensitivity single molecule digital counting by the stochastic labeling of a collection of identical molecules by attachment of a diverse set of labels. Each copy of a molecule randomly chooses from a non-depleting reservoir of diverse labels. Detection may be by a variety of methods including hybridization based or sequencing. Molecules that would otherwise be identical in information content can be labeled to create a separately detectable product that is unique or approximately unique in a collection. This stochastic transformation relaxes the problem of counting molecules from one of locating and identifying identical molecules to a series of binary digital questions detecting whether preprogrammed labels are present. The methods may be used, for example, to estimate the number of separate molecules of a given type or types within a sample.
Opening claim text (preview).
We claim: 1. A composition comprising a plurality of oligonucleotide labels, wherein each oligonucleotide label of the plurality of oligonucleotide labels comprises an oligo dT sequence, a sequencing primer binding site, a common sequence that is the same for all oligonucleotide labels of the plurality of oligonucleotide labels, and a unique label tag sequence, wherein the unique label tag sequence is selected from a set of at least m different label tag sequences. 2. The composition of claim 1 , further comprising a set of n target molecules hybridized to said plurality of oligonucleotide labels. 3. The composition of claim 2 , wherein the target molecules are RNA molecules. 4. The composition of claim 2 , wherein the target molecules are mRNA molecules. 5. The composition of claim 2 , wherein n has a value ranging from 1 to 100. 6. The composition of claim 2 , wherein n has a value ranging from 100 to 1,500. 7. The composition of claim 2 , wherein n has a value greater than 1,500. 8. The composition of claim 2 , wherein the target molecules comprise one or more different types of target molecules from a single cell. 9. The composition of claim 2 , wherein m is greater than n. 10. The composition of claim 9 , wherein a ratio m/n is greater than 5. 11. The composition of claim 1 , wherein m is between 100 and 1,000. 12. The composition of claim 1 , wherein m is between 1,000 and 10,000. 13. The composition of claim 1 , wherein the plurality of oligonucleotide labels are between 48 and 76 nucleotides in length. 14. A kit comprising a plurality of oligonucleotide labels, wherein each oligonucleotide label of the plurality of oligonucleotide labels comprises an oligo dT sequence, a sequencing primer binding site, a common sequence that is the same for all oligonucleotide labels of the plurality of oligonucleotide labels, and a unique label tag sequence, wherein the unique label tag sequence is selected from a set of at least m different label tag sequences. 15. The kit of claim 14 , wherein m is between 100 and 1,000. 16. The kit of claim 14 , wherein m is between 1,000 and 10,000. 17. The kit of claim 14 , wherein the plurality of oligonucleotide labels are between 48 and 76 nucleotides in length. 18. The kit of claim 14 , further comprising PCR amplification and sequencing reagents.
ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression · CPC title
using probe arrays or probe chips (C12Q1/6874 takes precedence) · CPC title
Methods for sequencing · CPC title
Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags · CPC title
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.